Preliminary research indicate conolidine may inhibit certain ion channels, minimizing neuronal excitability and limiting soreness signals. This mechanism is particularly relevant in neuropathic discomfort, where by irregular signaling brings about persistent discomfort. Additionally, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to soreness perception.... https://samueli147olg6.blog-a-story.com/profile